Journals / The Anatolian Journal of Cardiology / 2018 / Cilt: 19 - Sayı: 2

Association of serum prolidase activity in patients with isolated coronary artery ectasia

Pages
110–116
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The SPA value of 1170 U/L was predictive of CAE, with a sensitivity of 85% and specificity of 60%(AUC=0.854; 95% CI, 0.763–0.944; p<0.001).Conclusion: The activity of this enzyme was significantly correlated with CAE.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Coronary artery ectasia (CAE) is defined as an angiographic enlargement of a portion of the coronary artery between 1.5 and 2 timesthe diameter of the adjacent normal coronary artery.
📊
Key Findings & Data:It has been demonstrated that increased serum prolidase activity (SPA) is associated withincreased collagen turnover.
💡
Conclusion & Impact:The SPA value of 1170 U/L was predictive of CAE, with a sensitivity of 85% and specificity of 60%(AUC=0.854; 95% CI, 0.763–0.944; p<0.001).Conclusion: The activity of this enzyme was significantly correlated with CAE.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: Coronary artery ectasia (CAE) is defined as an angiographic enlargement of a portion of the coronary artery between 1.5 and 2 timesthe diameter of the adjacent normal coronary artery. It has been demonstrated that increased serum prolidase activity (SPA) is associated withincreased collagen turnover. We aimed to analyze the relationship between CAE and serum SPA levels.Methods: This study used a prospective case protocol design. A total of 40 consecutive patients with isolated right CAE and normal coronary arteries(23 men, 17 women; mean age, 62.4±10.8 years) were evaluated. The control group included the same number of consecutive patients withangiographically normal coronary arteries (20 men, 20 women; mean age, 63.8±11.1 years). Clinical characteristics, laboratory results, cardiovascularrisk factors, and medication use were recorded. SPA was measured using a spectrophotometer. Student’s t-test, Mann–Whitney U test,chi-square test, Pearson’s and Spearman’s correlations, logistic regression analysis, and ROC curve analysis were used for statistical analysis.Results: SPA was significantly higher in the CAE group compared with the control group (1635.2±492.0 U/L and 986.2±422.3 U/L, respectively;p<0.001). The relationship of SPA with CAE proved to be significant (r=0.512; p<0.001). SPA also served as an independent predictor of CAE(OR=1.003; 95% CI, 1.001–1.005; p=0.002). The SPA value of 1170 U/L was predictive of CAE, with a sensitivity of 85% and specificity of 60%(AUC=0.854; 95% CI, 0.763–0.944; p<0.001).Conclusion: The activity of this enzyme was significantly correlated with CAE.

🔖

Cite This Article

AKTÜRK, E., AŞKIN, L., NACAR, H., TAŞOLAR, M. H., TÜRKMEN, S., ÇETİN, M., BOZKURT, M. (2018). Association of serum prolidase activity in patients with isolated coronary artery ectasia. The Anatolian Journal of Cardiology, Cilt: 19 - Sayı: 2, 110–116. https://ajindex.com/articles/365239

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Yildiz A, Demirbag R, Yilmaz R, Gur M, Altiparmak IH, Akyol S, et al. The association of serum prolidase activity with the presence and severity of coronary artery disease. Coron Artery Dis 2008; 19: 319- 25. Erkus E, Altiparmak H, Sezen H, Kaya Z, Gunebakmaz O, Sezen Y, et al. Serum prolidase activity in patients with left ventricular diastolic dysfunction. Acta Cardiol 2015; 70: 51-7.
  2. Suner A, Nurdag A, Polat M, Kaya H, Koroglu S, Acar G, et al. Evaluation of serum prolidase activity in patients with slow coronary flow. Postepy Kardiol Interwencyjnej 2015; 11: 206-11.
  3. Sezen Y, Bas M, Altıparmak H, Yildiz A, Buyukhatipoglu H, Faruk Dag O, et al. Serum prolidase activity in idiopathic and ischemic cardiomyopathy patients. J Clin Lab Anal 2010; 24: 213-8.
  4. Yilmaz H, Sayar N, Yilmaz M, Tangürek B, Cakmak N, Gürkan U, et al. Coronary artery ectasia: clinical and angiographical evaluation. Turk Kardiyol Dern Ars 2008; 36: 530-5.
  5. Takajashi K, Ohyanagi M, Ikeoka K, Tateishi J, Iwasaki T. Clinical course of patients with coronary ectasia. Cardiology 1999; 91: 145- 49. Rabuş MB, Demirbağ R, Sezen Y, Taşar M, Taşkın A, Aksoy N, et al. Serum prolidase activity in patients with degenerative and rheumatic heart valve diseases. Turk J Med Sci 2010; 40: 687-92. Lijnen HR. Metalloproteinases in development and progression of vascular disease. Pathophysiol Haemost Thromb 2003;33: 275-81.
  6. Thomas CV, Coker ML, Zellner JL, Handy JR, Crumbley AJ, Spinale FG. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy. Circulation 1998; 97: 1708-15.
  7. Zeng B, Prasan A, Fung K, Solanki V, Bruce D, Freedman S, et al. Elevated circulating levels of matrix metalloproteinase- 9 and- 2 in patients with symptomatic coronary artery disease. Intern Med J 2005; 35: 331-5.
  8. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994; 94: 2493-503.
  9. Quyyumi AA, Dakak N, Andrews NP, Husain S, Arora S, Gilligan DM, et al. Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. J Clin Invest 1995; 95: 1747-55.
  10. Kahraman F, Karabacak M, Türker Y. Serum nitric oxide level in patients with coronary artery ectasia. Anatol J Cardiol 2017; 17: 341. Kajinami K, Kasashima S, Oda Y, Koizumi J, Katsuda S, Mabuchi H. Coronary ectasia in familia